TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced operating and financial results for the three months ended March 31, 2008. For the first quarter of 2008, EpiCept’s net loss attributable to common stockholders was $6.1 million, or $0.13 per share, compared with a net loss attributable to common stockholders of $7.7 million, or $0.24 per share, for the first quarter of 2007. As of March 31, 2008, EpiCept had 51.3 million shares outstanding.
